Please wait while the formulary information is being retrieved.
GEMFIBROZIL (GEMFIBROZIL)
- Hypertriglyceridemia
- Primary prevention of coronary heart disease
600 mg tablet
- 1 tablet (600 mg) by oral route 2 times per day 30 minutes before morning and evening meal
600 mg tablet
- 1 tablet (600 mg) by oral route 2 times per day 30 minutes before morning and evening meal
Hypertriglyceridemia
- 1 tablet (600 mg) by oral route 2 times per day 30 minutes before morning and evening meal
Primary prevention of coronary heart disease
- 1 tablet (600 mg) by oral route 2 times per day 30 minutes before morning and evening meal
- alogliptin-pioglitazone
- Duetact
- ezetimibe-simvastatin
- niacin-simvastatin
- Oseni
- pioglitazone-glimepiride
- Prandimet
- Prandin
- repaglinide
- repaglinide-metformin
- Simcor
- simvastatin
- Vytorin 10-10
- Vytorin 10-20
- Vytorin 10-40
- Vytorin 10-80
- Zocor
Contraindicated
- Actoplus Met
- Actoplus Met Xr
- Actos
- Advicor
- Altoprev
- amlodipine-atorvastatin
- atorvastatin
- Caduet
- Coumadin
- Crestor
- dabrafenib
- enzalutamide
- ezetimibe-atorvastatin
- fluvastatin
- Jantoven
- Lescol
- Lescol Xl
- Lipitor
- Liptruzet
- Livalo
- lovastatin
- Mevacor
- niacin-lovastatin
- pioglitazone
- pioglitazone-metformin
- pitavastatin
- Pravachol
- pravastatin
- rosuvastatin
- Tafinlar
- warfarin
- Xtandi
Severe
Moderate
- Anti-diarrhea
- Anti-diarrheal (lope)-anti-gas
- Anti-diarrheal (loperamide)
- cholestyramine (with sugar)
- Cholestyramine Light
- cholestyramine-aspartame
- colchicine
- colchicine-probenecid
- Colcrys
- colesevelam
- Colestid
- Colestid Flavored
- colestipol
- Diamode
- ezetimibe
- Imodium Multi-symptom Relief
- Lo-peramide
- loperamide
- loperamide-simethicone
- Orenitram
- Prevalite
- Questran
- Questran Light
- Remodulin
- treprostinil
- treprostinil diolamine
- treprostinil sodium
- treprostinil-neb accessories
- treprostinil-nebulizer-accesor
- Tyvaso
- Tyvaso Refill Kit
- Tyvaso Starter Kit
- Ultra A-d
- Welchol
- Zetia
- Biliary calculus
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
- Disease of liver
- Gallbladder disease
- Lactating mother
- Primary biliary cirrhosis
Contraindicated
- Anemia
Severe
Moderate
- Leukopenia
- Thrombocytopenic disorder
GEMFIBROZIL (GEMFIBROZIL)
- Hypertriglyceridemia
- Primary prevention of coronary heart disease
- None
- Acute abdominal pain
- Dyspepsia
More Frequent
Severe
Less Severe
- Appendicitis
- Constipation
- Diarrhea
- Dysgeusia
- Eczema
- Fatigue
- Headache disorder
- Limb pain
- Nausea
- Skin rash
- Vertigo
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Anemia
- Angioedema
- Atrial fibrillation
- Biliary calculus
- Bone marrow hypoplasia
- Exfoliative dermatitis
- Gallbladder disease
- Increased alanine transaminase
- Increased aspartate transaminase
- Laryngeal edema
- Leukopenia
- Myopathy
- Myositis
- Obstructive hyperbilirubinemia
- Rhabdomyolysis
Less Severe
- Arthralgias
- Blurred vision
- Depression
- Dizziness
- Drowsy
- Eosinophilia
- Erectile dysfunction
- Hypesthesia
- Libido changes
- Muscle weakness
- Myalgias
- Paresthesia
- Peripheral neuritis
- Pruritus of skin
- Skin inflammation
- Synovitis
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Gemfibrozil
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Gemfibrozil
- Severity Level:
2
- Additional Notes: Adverse effects seen in animals at 0.5 to 3 times the mrhd
Contraindicated
Gemfibrozil
Tumorigenic in animal studies;Molecular wt low enough for possible excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Tumorigenic in animal studies;Molecular wt low enough for possible excretion |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Hypertriglyceridemia | |
| E78.1 | Pure hyperglyceridemia |
| E78.2 | Mixed hyperlipidemia |
| 0-9 | A-Z |
|---|---|
| E78.1 | Pure hyperglyceridemia |
| E78.2 | Mixed hyperlipidemia |
Formulary Reference Tool